Skip to content

Safety and Efficacy of Immune Therapy for Condyloma

Safety and Efficacy of Immune Therapy for Condyloma

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03158480
Enrollment
80
Registered
2017-05-18
Start date
2017-06-25
Completion date
2019-06-30
Last updated
2017-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condylomata Acuminata

Keywords

DC-CIK, interferon

Brief summary

Cytokine-induced killer (CIK) cells will be co-cultured with HPV induced dendritic cells (DCs); HPV specific DC-CIK will be induced to Condylomata Acuminata patients using interferon, whose recurrence rate and total cost will be compared to Condylomata Acuminata patients only use interferon.

Interventions

Cytokine-induced killer (CIK) cells are co-cultured with HPV induced dendritic cells (DCs); HPV specific DC-CIK will be induced to condylomata acuminata patients

Sponsors

Shenzhen Second People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

All patients have typical clinical characters of condyloma, positive for HPV-DNA test; All patients have been treated for cryotherapy or laser plus interferon for over half a year without completely recovery. All patients or their family will sign informed consent and approved by Ethics Committee of Shenzhen Second People's Hospital -

Exclusion criteria

pregnant, blood disease, contraindication for immune therapy, allergic to interferon \-

Design outcomes

Primary

MeasureTime frameDescription
Condylomata Acuminata recurrence rate6 monthsCondylomata Acuminata recurrence rate in 6 months after treatment

Secondary

MeasureTime frameDescription
skin tissue HPV gene6 monthsuse PCR to testify skin tissue HPV gene
side effect6 monthsevaluate and record side effect of each group

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026